Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.1.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.19NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HN.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HN.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
HN.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
HN.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.47ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.47ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.47ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.47NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.23ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.23NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.4.2.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.4.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.4.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.4.2.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-20389.3US
LK.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LK.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LK.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDSORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDSENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDSENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDSNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LY.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LY.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LY.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LY.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDQ.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDQ.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDQ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDQ.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.18ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.18ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.18NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GJ.1.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GJ.1.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GJ.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GJ.1.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.3.2.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.3.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.2.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used